MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 207 filers reported holding MEDIVATION INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $67,047,000 | -2.3% | 1,111,880 | -25.5% | 0.08% | -5.0% |
| Q1 2016 | $68,640,000 | +7.2% | 1,492,831 | +12.7% | 0.08% | +9.6% |
| Q4 2015 | $64,059,000 | +1.4% | 1,325,156 | -10.8% | 0.07% | +4.3% |
| Q3 2015 | $63,169,000 | -26.8% | 1,486,339 | +96.6% | 0.07% | -15.7% |
| Q2 2015 | $86,354,000 | -13.9% | 756,156 | -2.7% | 0.08% | -14.4% |
| Q1 2015 | $100,321,000 | +34.2% | 777,269 | +3.5% | 0.10% | +36.6% |
| Q4 2014 | $74,775,000 | +17.3% | 750,682 | +16.4% | 0.07% | +12.7% |
| Q3 2014 | $63,747,000 | +20.4% | 644,748 | -6.2% | 0.06% | +18.9% |
| Q2 2014 | $52,967,000 | +0.8% | 687,166 | -15.8% | 0.05% | -5.4% |
| Q1 2014 | $52,547,000 | +24.3% | 816,322 | +23.2% | 0.06% | +16.7% |
| Q4 2013 | $42,275,000 | +2.7% | 662,420 | -3.5% | 0.05% | -5.9% |
| Q3 2013 | $41,154,000 | +38.8% | 686,588 | +13.9% | 0.05% | +34.2% |
| Q2 2013 | $29,650,000 | – | 602,634 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |